$ARDX
ARDELYX, INC.

2021 Q4 Form 10-Q Financial Statement

#000162828021022978 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $1.029M $1.173M $2.713M
YoY Change -43.12% -56.76% -9.96%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Gross Profit $1.029M $1.173M $2.713M
YoY Change -43.15% -56.76% 12.43%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $14.23M $17.31M $7.630M
YoY Change 25.52% 126.92% 10.26%
% of Gross Profit 1383.28% 1476.04% 281.24%
Research & Development $19.47M $23.70M $12.24M
YoY Change 7.5% 93.59% -30.38%
% of Gross Profit 1891.93% 2020.03% 451.16%
Depreciation & Amortization $194.0K $460.0K $440.0K
YoY Change -53.81% 4.55% -31.25%
% of Gross Profit 18.85% 39.22% 16.22%
Operating Expenses $33.70M $23.70M $12.24M
YoY Change 14.44% 93.59% -30.38%
Operating Profit -$32.67M -$42.24M -$17.16M
YoY Change 18.21% 146.12% -22.31%
Interest Expense -$984.0K $1.216M $1.202M
YoY Change -24.89% 1.16% -16.7%
% of Operating Profit
Other Income/Expense, Net $23.00K -$134.0K $255.0K
YoY Change -71.25% -152.55% -13.27%
Pretax Income -$36.23M -$43.59M -$18.11M
YoY Change 25.51% 140.7% -22.08%
Income Tax $0.00 $1.000K $0.00
% Of Pretax Income
Net Earnings -$36.23M -$43.59M -$18.11M
YoY Change 25.48% 140.71% -23.07%
Net Earnings / Revenue -3521.28% -3715.86% -667.45%
Basic Earnings Per Share -$0.42 -$0.20
Diluted Earnings Per Share -$314.0K -$0.42 -$0.20
COMMON SHARES
Basic Shares Outstanding 112.7M shares 104.1M shares 89.37M shares
Diluted Shares Outstanding 104.1M shares 89.37M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $116.7M $141.7M $185.5M
YoY Change -37.43% -23.64% 79.22%
Cash & Equivalents $72.43M $75.29M $91.01M
Short-Term Investments $44.26M $66.36M $94.49M
Other Short-Term Assets $16.46M $11.44M $7.500M
YoY Change 100.71% 52.55% 63.04%
Inventory $0.00
Prepaid Expenses
Receivables $502.0K $287.0K $800.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $133.6M $153.4M $193.8M
YoY Change -31.35% -20.85% 74.9%
LONG-TERM ASSETS
Property, Plant & Equipment $2.362M $2.651M $2.111M
YoY Change 22.0% 25.58% -74.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0%
Other Assets $1.150M $1.238M $249.0K
YoY Change 108.33% 397.19% 24.5%
Total Long-Term Assets $16.26M $17.47M $4.762M
YoY Change 136.53% 266.84% -44.63%
TOTAL ASSETS
Total Short-Term Assets $133.6M $153.4M $193.8M
Total Long-Term Assets $16.26M $17.47M $4.762M
Total Assets $149.9M $170.8M $198.6M
YoY Change -25.62% -13.95% 66.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.277M $4.263M $2.490M
YoY Change -23.98% 71.2% -7.78%
Accrued Expenses $14.98M $19.53M $13.20M
YoY Change 17.01% 47.98% -5.71%
Deferred Revenue $0.00 $527.0K
YoY Change -100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $32.26M $44.44M $0.00
YoY Change 668.19%
Total Short-Term Liabilities $52.82M $68.77M $16.53M
YoY Change 85.88% 315.92% -6.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $7.032M $50.70M
YoY Change -100.0% -86.13% 1.81%
Other Long-Term Liabilities $14.48M $13.62M $0.00
YoY Change 3518.75% -100.0%
Total Long-Term Liabilities $14.48M $20.65M $50.70M
YoY Change -69.2% -59.27% -3.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.82M $68.77M $16.53M
Total Long-Term Liabilities $14.48M $20.65M $50.70M
Total Liabilities $67.30M $89.42M $67.22M
YoY Change -10.81% 33.03% -4.39%
SHAREHOLDERS EQUITY
Retained Earnings -$712.9M -$676.7M -$525.9M
YoY Change 28.51% 28.68%
Common Stock $795.6M $758.1M $657.1M
YoY Change 16.84% 15.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $82.62M $81.43M $131.3M
YoY Change
Total Liabilities & Shareholders Equity $149.9M $170.8M $198.6M
YoY Change -25.62% -13.95% 66.29%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$36.23M -$43.59M -$18.11M
YoY Change 25.48% 140.71% -23.07%
Depreciation, Depletion And Amortization $194.0K $460.0K $440.0K
YoY Change -53.81% 4.55% -31.25%
Cash From Operating Activities -$39.47M -$34.59M -$19.88M
YoY Change 124.38% 73.99% -3.59%
INVESTING ACTIVITIES
Capital Expenditures $95.00K -$445.0K -$40.00K
YoY Change -138.0% 1012.5% -66.67%
Acquisitions
YoY Change
Other Investing Activities $22.00M $18.58M $9.640M
YoY Change -762.68% 92.72% -59.08%
Cash From Investing Activities $22.10M $18.13M $9.600M
YoY Change -718.94% 88.89% -59.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.51M 4.999M 790.0K
YoY Change -31.51% 532.78% 276.19%
NET CHANGE
Cash From Operating Activities -39.47M -34.59M -19.88M
Cash From Investing Activities 22.10M 18.13M 9.600M
Cash From Financing Activities 14.51M 4.999M 790.0K
Net Change In Cash -2.860M -11.46M -9.490M
YoY Change -9633.33% 20.73% -413.2%
FREE CASH FLOW
Cash From Operating Activities -$39.47M -$34.59M -$19.88M
Capital Expenditures $95.00K -$445.0K -$40.00K
Free Cash Flow -$39.56M -$34.14M -$19.84M
YoY Change 128.17% 72.1% -3.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001437402
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36485
dei Entity Registrant Name
EntityRegistrantName
ARDELYX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1303944
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Fifth Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02451
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
745-1700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
ARDX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
112743408 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75288000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91032000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66363000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
95452000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
287000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11441000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8202000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
153379000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
194686000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2651000 USD
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1936000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
2114000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13580000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2274000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1238000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
552000 USD
CY2021Q3 us-gaap Assets
Assets
170848000 USD
CY2020Q4 us-gaap Assets
Assets
201562000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4263000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5626000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4770000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5672000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3391000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2117000 USD
CY2021Q3 us-gaap Loans Payable Current
LoansPayableCurrent
44444000 USD
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
4167000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
527000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4177000 USD
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
11373000 USD
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
6657000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
68768000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28416000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10669000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
413000 USD
CY2021Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
7032000 USD
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
46621000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2947000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 USD
CY2021Q3 us-gaap Liabilities
Liabilities
89416000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
75450000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106771584 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106771584 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93599975 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93599975 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
9000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
758114000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
680872000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-676696000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-554765000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
81432000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
126112000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
170848000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201562000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1173000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2713000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9068000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5762000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
1000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
141000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23695000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12240000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70172000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46948000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19714000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7634000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56969000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21810000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
43409000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
19874000 USD
us-gaap Costs And Expenses
CostsAndExpenses
128141000 USD
us-gaap Costs And Expenses
CostsAndExpenses
68899000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-42236000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17161000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-119073000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-63137000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
1216000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
1202000 USD
us-gaap Interest Expense
InterestExpense
3518000 USD
us-gaap Interest Expense
InterestExpense
3785000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-134000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
255000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
664000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1485000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43586000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18108000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-121927000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65437000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-43587000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121931000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65437000 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104144606 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104144606 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89365798 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89365798 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100480156 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100480156 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89109772 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89109772 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-43587000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121931000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65437000 USD
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-227000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
7000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
70000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43588000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18335000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-121924000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65367000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
117569000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
341000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
190000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000 USD
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
106000 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4743000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2262000 USD
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-43587000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
81432000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
126112000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
819000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
190000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
584000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
106000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
67189000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8568000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
7000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121931000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
81432000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
146350000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
459000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
339000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2527000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-227000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131340000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
186655000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
834000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
310000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
759000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8149000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
70000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65437000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131340000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121931000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65437000 USD
us-gaap Depreciation
Depreciation
1247000 USD
us-gaap Depreciation
Depreciation
1399000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
477000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
416000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
192000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
235000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-396000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
241000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2257000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1568000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8568000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8149000 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-696000 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
290000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
212000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
393000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
287000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3927000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3748000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1363000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
303000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-902000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-731000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2033000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1914000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5411000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-871000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-703000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3656000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113082000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63845000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
103550000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
79402000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
72736000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
107200000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1962000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28852000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27872000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
67189000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1403000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1593000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
106000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68486000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1593000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15744000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-90124000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91032000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
181133000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75288000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91009000 USD
us-gaap Interest Paid Net
InterestPaidNet
2920000 USD
us-gaap Interest Paid Net
InterestPaidNet
3119000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14379000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Stock Issued1
StockIssued1
190000 USD
us-gaap Stock Issued1
StockIssued1
310000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes thereto. On an ongoing basis, management evaluates its estimates, including those related to recognition of revenue, clinical trial accruals, contract manufacturing accruals, the fair value of assets and liabilities, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could materially differ from those estimates.</span></div>
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
141700000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75288000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
75288000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
66360000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66363000 USD
CY2021Q3 us-gaap Investments And Cash
InvestmentsAndCash
141648000 USD
CY2021Q3 ardx Investments And Cash Accumulated Gross Unrealized Gain
InvestmentsAndCashAccumulatedGrossUnrealizedGain
6000 USD
CY2021Q3 ardx Investments And Cash Accumulated Gross Unrealized Loss
InvestmentsAndCashAccumulatedGrossUnrealizedLoss
3000 USD
CY2021Q3 ardx Investments And Cash Fair Value Disclosure
InvestmentsAndCashFairValueDisclosure
141651000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91032000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
91032000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
95455000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
95452000 USD
CY2020Q4 us-gaap Investments And Cash
InvestmentsAndCash
188602000 USD
CY2020Q4 ardx Investments And Cash Accumulated Gross Unrealized Gain
InvestmentsAndCashAccumulatedGrossUnrealizedGain
7000 USD
CY2020Q4 ardx Investments And Cash Accumulated Gross Unrealized Loss
InvestmentsAndCashAccumulatedGrossUnrealizedLoss
11000 USD
CY2020Q4 ardx Investments And Cash Fair Value Disclosure
InvestmentsAndCashFairValueDisclosure
188598000 USD
CY2021Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2020Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 investment
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
52475000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
307000 USD
CY2021Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
692000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
51476000 USD
CY2021Q3 us-gaap Loans Payable Current
LoansPayableCurrent
44444000 USD
CY2021Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
7032000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3391000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10669000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
14060000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13580000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0686
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1096000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
648000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
2606000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1944000 USD
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
829000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
767000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2383000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2288000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1056000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4292000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4440000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4589000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1321000 USD
CY2021Q3 ardx Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
252000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15950000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1890000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
14060000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3391000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10669000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2262000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2527000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8568000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8149000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9790000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3410000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.60
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
331000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1481000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.01
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11387000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.95
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6434000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.51
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-43587000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000 USD
us-gaap Net Income Loss
NetIncomeLoss
-121931000 USD
us-gaap Net Income Loss
NetIncomeLoss
-65437000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104145000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104145000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89366000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89366000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100480000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100480000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89110000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89110000 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13400000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10400000 shares
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2021Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD

Files In Submission

Name View Source Status
0001628280-21-022978-index-headers.html Edgar Link pending
0001628280-21-022978-index.html Edgar Link pending
0001628280-21-022978.txt Edgar Link pending
0001628280-21-022978-xbrl.zip Edgar Link pending
ardx-20210930.htm Edgar Link pending
ardx-20210930.xsd Edgar Link pending
ardx-20210930xex311.htm Edgar Link pending
ardx-20210930xex312.htm Edgar Link pending
ardx-20210930xex321.htm Edgar Link pending
ardx-20210930_cal.xml Edgar Link unprocessable
ardx-20210930_def.xml Edgar Link unprocessable
ardx-20210930_g1.jpg Edgar Link pending
ardx-20210930_htm.xml Edgar Link completed
ardx-20210930_lab.xml Edgar Link unprocessable
ardx-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending